India's Shilpa Medicare rises on Saudi clearance for Bengaluru facility
10/07/2025 11:12
** Shares of Shilpa Medicare SHME.NS rise 2.6% to 870.25 rupees ** Stock set to snap three-session losing streak ** Saudi Food and Drug Authority give pharma co's Bengaluru facility a good manufacturing practices certification from ** SHME up ~7% YTD (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026